In a large-scale analysis, researchers determined whether endovascular mechanical thrombectomy is a safe and effective therapy for acute ischemic stroke during pregnancy and the postpartum period.
Researchers in China developed a wearable Doppler device to test whether it could provide a noninvasive accurate measurement of blood flow velocity in human arteries and enhance quality of care following reconstruction surgery.
An AAO 2021 presentation reviewed clinical trial data of intravitreal pegcetacoplan, a targeted C3 inhibitor, in controlling lesion growth in patients with geographic atrophy.
A team of investigators conducted a cross-sectional study to explore the association between an increased pain threshold and risk of self-harm in youth.
The researchers sought to determine the clinical and biochemical features of alemtuzumab-induced autoimmune thyroid events and look their risk factors with a focus on fluctuating Graves’ disease.
Presenting at AAO 2021, researchers examined the efficacy of intravenous infusions of teprotumumab, an IGF-IR inhibitor, in patients with thyroid eye disease with low inflammation.
